Unknown

Dataset Information

0

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues.


ABSTRACT: The therapeutic effects of gene therapy using adeno-associated virus (AAV) vectors are dependent on the efficacy of viral transduction. Currently, we have reached the safe limits of AAV vector dose, beyond which damaging inflammatory responses are seen. To improve the efficacy of AAV transduction, we treated mouse embryonic fibroblasts, primate retinal pigment epithelial cells, and human retinal explants with hydroxychloroquine (HCQ) 1 h prior to transduction with an AAV2 vector encoding GFP driven by a ubiquitous CAG promoter. This led to a consistent increase in GFP expression, up to 3-fold, compared with vector alone. Comparing subretinal injections of AAV2.CAG.GFP vector alone versus co-injection with 18.75 ?M HCQ in paired eyes in mice, mean GFP expression was 4.6-fold higher in retinae co-treated with HCQ without retinal toxicity. A comparative 5.9-fold effect was seen with an AAV8(Y733F).GRK1.GFP vector containing the photoreceptor-specific rhodopsin kinase promoter. While the mechanism of action remains to be fully elucidated, our data suggest that a single pulse of adjunctive HCQ could safely improve AAV transduction in vivo, thus providing a novel strategy for enhancing the clinical effects of gene therapy.

SUBMITTER: Chandler LC 

PROVIDER: S-EPMC6606965 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues.

Chandler Laurel C LC   Barnard Alun R AR   Caddy Sarah L SL   Patrício Maria I MI   McClements Michelle E ME   Fu Howell H   Rada Cristina C   MacLaren Robert E RE   Xue Kanmin K  

Molecular therapy. Methods & clinical development 20190604


The therapeutic effects of gene therapy using adeno-associated virus (AAV) vectors are dependent on the efficacy of viral transduction. Currently, we have reached the safe limits of AAV vector dose, beyond which damaging inflammatory responses are seen. To improve the efficacy of AAV transduction, we treated mouse embryonic fibroblasts, primate retinal pigment epithelial cells, and human retinal explants with hydroxychloroquine (HCQ) 1 h prior to transduction with an AAV2 vector encoding GFP dri  ...[more]

Similar Datasets

| S-EPMC2670546 | biostudies-literature
| S-EPMC7464341 | biostudies-literature
| S-EPMC3814817 | biostudies-literature
| S-EPMC4259838 | biostudies-literature
| S-EPMC3640772 | biostudies-literature
| S-EPMC9892335 | biostudies-literature
| S-EPMC6404499 | biostudies-literature
| S-EPMC4064737 | biostudies-literature
| S-EPMC5177998 | biostudies-literature
| S-EPMC10572999 | biostudies-literature